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1. INTRODUCTION
Actinic keratosis (AK) represents in situ dysplasia resulting from sun exposure. It is found chiefly on the chronically sun-exposed surfaces of  the face, ears, 
balding scalp, dorsal hands, and forearms (James et al., 2016). 
Lesions vary in size from <1 mm to over 2 cm and are usually 
asymptomatic (Girish et al., 2016). AK initially appears as a 
tiny, palpable lesion on normal sun-exposed skin that gradually 
enlarges and becomes red and scaly. The overlying scale may 
be extended to the point that markedly exophytic cutaneous 
horns are produced (Fitzpatrick and Morelli, 2011) although 
the rate of  progression of  an individual AK to invasive 
squamous cell carcinoma (SCC) has been estimated to be low 
(<0.1%) (Salasche, 2000). AKs are clinically important lesions, 
not only due to their potential to develop into SCC but because 
they are one of  the strongest predictors that an individual may 
subsequently develop melanoma or nonmelanoma skin cancer 
(Zhang et al., 2010). Various risk factors have been identified 
for the expression of  AKs. The two major ones are individual 
susceptibility and cumulative ultraviolet radiation exposure. 
One of  the most important susceptibility risk factors is age. 
Another individual risk factor is immunosuppression, because 
it is known that organ transplant recipients and patients 
receiving certain chemotherapy agents and possibly even 
biologic therapies are at increased risk of  developing AKs 
and SCCs (Duncan et al., 2011).
Treatment modalities for AKs can be broadly divided into: 
Lesion-Targeted therapies and field therapies (Duncan et al., 
2011).
1.1. Lesion-Targeted Therapies
• Liquid nitrogen cryotherapy
• Curettage with or without electrosurgery
• Shave excision.
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A B S T R A C T
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1.2. Field Therapies
1.2.1. Topical
• 5-fluorouracil cream and solution
• 5 % imiquimod cream




• Medium-depth chemical peel
• Deep chemical peel
• Laser resurfacing
• Photodynamic therapy (Duncan et al., 2011).
Cryosurgery is the controlled application of  cold to cause 
tissue damage. It can be used to treat both benign and 
malignant skin conditions. With cryosurgery, the degree of  
tissue damage is controlled to destroy the target lesion with 
minimal damage to normal surrounding tissue (Fitzpatrick 
and Morelli, 2011). Liquid nitrogen is the cryogen of  choice 
in dermatology. It is easy to store and use, environmentally 
friendly, non-flammable, and inexpensive (Duncan et al., 2011). 
It is the liquid state of  gaseous nitrogen. It is extremely cold, 
boiling at minus −198.8°C. (−320.4 F). It is necessary to store 
and transport it in special flanks (The British Association of  
Dermatology, 2008). Cryotherapy is believed to cause cell death 
by ice crystals formation in the cell damage cellular components 
(James et al., 2016). Chemical peeling is the application of  a 
chemical agent to the skin, which causes controlled destruction 
of  a part or entire epidermis, with or without the dermis, leading 
to exfoliation, and removal of  superficial lesions followed by 
regeneration of  new epidermal and dermal tissues (Khunger 
and Iadvl, 2008). Trichloroacetic acid (TCA) in concentrations 
of  10–25% is used extensively as a superficial peel. The depth 
of  injury is related to the concentration and the number of  
applications, with repeated coats of  a low-concentration TCA 
leading to greater penetration (James et al., 2016). Chemical peels 
can eliminate AKs and may be able to provide prophylaxis for 
a prolonged time period (Kligman et al., 1985). Chemical peels 
with TCA should be avoided in case of  presence of  either 
active infections like (bacterial ,viral and fungal) or presence 
of  preexisting dermatological diseases like psoriasis and atopic 
dermatitis and also when there is history of  photosensitizing 
drug reaction.
2. MATERIALS AND METHODS
A comparative study comparing two types of  therapy in the 
treatment of  AK was conducted in the Erbil dermatology 
teaching center in Erbil city of  Kurdistan Region-Iraq, from 
March 2018 to January 2019. The study population were 
44 patients diagnosed clinically as having AK.
Lesions larger than 3 mm in its greatest diameter on face 
and scalp with age over 20 years were included. Males and 
females had the same chance to be included in this research 
study. Demographic data were collected from patients by 
direct interview including name, age, residence, occupation, 
number, site, duration of  the lesion, grade of  the lesion, 
type of  skin, history of  sun exposure, and history of  other 
skin disease and others were recorded in the predesigned 
questionnaire. Lesions were graded according to the following 
criteria (Thai et al., 2004).
• Grade1. Mild-slightly palpable lesions, better felt than 
seen
• Grade2. Moderate-moderately thick AK, easily felt and 
seen
• Grade3. Severe-very thick and/or obvious AK 
(Thai et al., 2004).
The following lesions were excluded: (1) Grade three lesions, 
(2) lesions <2 mm in their greatest diameter, (3) lesions 
not located on face and scalp, (4) lesions were small in size 
and multiple that definitive borders cannot be determined, 
(5) patients who received other treatment modalities or 
have previous history of  radiotherapy or chemotherapy, 
(6) immune-deficient patients (cancer chemotherapy, systemic 
corticosteroid, renal transplant status, etc.), (7) patient who 
have history of  keloid formation, and (8) patient with 
contraindication criteria for cryotherapy and TCA chemical 
peels. Patients were randomly allocated to one of  the two 
groups:
2.1. Cryotherapy Group
Twenty-two patients were included; they were treated by 
cryotherapy by applying a handheld (−198°C) liquid nitrogen 
unit using the direct open spray technique. Spray gun was 
held perpendicular to the lesion, at a distance of  1–2 cm so 
that uniform freezing of  the lesion with a 1–2 mm rim of  
frozen tissue, beyond the marked outline could be achieved. 
We used a single timed freeze-thaw cycle. The freeze time 
was 10 s. Patients were followed every 2–3 weeks apart.
2.2. TCA Acid Group
Twenty-two patients were included; TCA 25% was prepared 
by adding 25 g of  TCA to 75 ml of  distilled water which was 
produced by Automatic Water Still machine that reserves 
water automatically also it has to overheat safety sensor, its 
sterile pathogen free. Then, it was applied on the lesion with 
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cotton-tipped applicator or gauze. Left in its place till frosting 
was appeared. Then, the patients were asked to wash their 
face with cold water until the burning sensation subsides. 
Patients were followed up every 2–3 weeks apart.
At last, both groups were advised to avoid sunlight and apply 
broad-spectrum sunscreen.
Both groups received a maximum of  four to five treatment 
sessions. The response of  each lesion was clinically classified 
by investigators as a good response when there is the 
complete disappearance of  the lesion, moderate response 
when there is partial disappearance and poor response when 
the lesion is still present regardless of  size.
The study was approved by the Ethics Committee of  
the college of  medicine; Hawler Medical University and 
permission letter from Erbil directorate of  health were 
obtained. The purpose of  the study carefully explained to 
each participant, and informed verbal consent was obtained 
from them. Statistical Package for the Social Sciences, SPSS, 
version 23 was used for data analysis.
3. RESULTS
There was no statistically significant difference between the two 
groups regarding their age (P = 0.1). No significant differences 
were observed between the patients treated with cryotherapy 
and the patients treated with TCA regarding gender (P = 0.2), 
occupation (P = 0.1), and residence (P = 0.2) [Table 1].
No significant differences were observed between the 
patients treated with cryotherapy and the patients treated with 
TCA regarding AK disease duration (P = 0.4), grade of  lesion 
(P = 10), skin phototype (P = 0.1), itching (P = 0.2), and skin 
cancer (P = 0.6). The outdoor occupation was significantly 
higher among AK patients treated with TCA in comparison 
to patients treated with cryotherapy (P = 0.002) [Table 2].
Although no significant differences were observed between 
the patients treated with cryotherapy and the patients treated 
with TCA regarding a number of  sessions (P = 0.1), 3 (13.6%) 
the patients treated with more than 5 sessions of  cryotherapy 
in comparison to no patients with TCA treated with more 
than 5 sessions. The positive periorbital AK was equal for 
both groups, while cheek, forehead, and nasal AK were close 
in both study groups with no significant difference. The 
temporal and scalp AK were also not significantly different 
in both study groups [Table 3].
There was a significant association between good response 
to treatment and cryotherapy (P = 0.02); poor response was 
significantly higher among the patients treated with TCA 
(36.4%) in comparison to cryotherapy (4.5%). The post-
treatment side effects between the study groups were not 
significantly different; redness was present in all the patients 
of  both groups after treatment. Dyspigmentation was not 
significantly different between both study groups (P = 0.1); 
However, hyperpigmentation was higher in patients treated 
with TCA, while hypopigmentation was higher in the patients 
treated with cryotherapy [Table 4].
4. DISCUSSION
AK is regarded as one of  the most common dermatological 
diseases globally (Berlin, 2010). The interesting characteristic 
of  AK is their liability in development to squamous cell 
cancer. For that, early treatment of  AK is preferred. Many 
destructive measures were used in the treatment of  AK such 
as cryotherapy, TCA, curette, carbon dioxide, and erbium: 
YAG laser (Berlin, 2010). The present study showed a 
significant improvement of  AK treated with cryotherapy in 
comparison to AK treated with TCA (P = 0.02). This finding 
is consistent with results of  Lugo-Janer et al. which found 
that the cryotherapy is superior to TCA in the treatment 
of  AK but the cryotherapy was painful and needs longer 
time(Lugo-Jan et al., 2003).
The current study showed no significant differences between 
two study groups regarding side effects such as redness 
Table 1: Distribution of actinic keratosis patient’s 
demographic characteristics according to treatment 
types (n=44).







0.1*<50 3 (13.6) 8 (36.4) 
50–59 5 (22.7) 4 (18.2)
60–69 8 (36.4) 3 (13.6) 
≥70 6 (27.3) 7 (31.8)
Gender
0.2*Male 11 (50.0) 7 (31.8) 
Female 11 (50.0) 15 (68.2)
Occupation
0.1*Indoor 20 (90.9) 22 (100.0) 
Outdoor 2 (9.1) 0 (0)
Residence
0.2*Urban 20 (90.9) 17 (77.3) 
Rural 2 (9.1) 5 (22.7)
*Not significant
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Table 2: Distribution of actinic keratosis disease characteristics according to the treatment types (n=44)
Variable Cryotherapy (n=22) No. (%) Trichloroacetic acid (n=22) No. (%) P-value
Duration of diseases (months)
0.4*≤6 7 (31.8) 5 (22.7)
>6 15 (68.2) 17 (77.3)
Grade of lesion
Mild 2 (9.1) 2 (9.1) 1.0*
Moderate 20 (90.9) 20 (90.9)
Skin phototype
0.1*Type II 4 (18.2) 0 (0)
Type III 11 (50.0) 13 (59.1)
Type IV 7 (31.8) 9 (40.9)
Itching
0.2*Yes 10 (45.5) 14 (63.6)
No 12 (54.5) 8 (36.4)
Skin cancer
0.6*Yes 4 (18.2) 3 (13.6)
No 18 (81.8) 19 (86.4)
Previous occupation 0.002**
Indoor 13 (59.1) 3 (13.6)
Outdoor 9 (40.9) 19 (86.4)
*Not significant, **Significant
Table 3: Distribution of therapeutic characteristics for AK disease according to the treatment types (n=44)
Variable Cryotherapy (n=22) No. (%) Trichloroacetic acid (n=22) No. (%) P-value
Number of sessions
0.1*1 0 (0) 1 (4.5)
2 2 (9.1) 4 (18.2)
3 5 (22.7) 2 (9.1)
4 6 (27.3) 3 (13.6)
5 6 (27.3) 12 (54.6)
>5 3 (13.6) 0 (0)
Periorbital AK
Yes 5 (22.7) 5 (22.7) 1.0*
No 17 (77.3) 17 (77.3)
Cheek AK
0.7*Yes 8 (36.4) 9 (40.9)
No 14 (63.6) 13 (59.1)
Forehead AK
0.6*Yes 4 (18.2) 3 (13.6)
No 18 (81.8) 19 (86.4)
Nose AK 0.5*
Yes 12 (54.5) 14 (63.6)
No 10 (45.5) 8 (36.4)
Temporal AK 0.1*
Yes 6 (27.3) 2 (9.1)
No 16 (72.7) 20 (90.9)
Scalp AK 0.1*
Yes 1 (4.5) 2 (9.1)
No 21 (95.5) 20 (90.9)
*Not significant, AK: Actinic keratosis
and dyspigmentation. Although no significant difference, 
hypopigmentation was more among AK patients treated 
with cryotherapy. This finding is consistent with the results 
of  other study (Vachiramon and Thadanipon, 2011). In 
our study, the outdoor occupation was significantly higher 
among AK patients treated with TCA in comparison to 
patients treated with cryotherapy (P = 0.002). This finding 
may be attributed to many factors related to TCA such as 
easily application and cost that make it highly preferred by 
outdoor workers and dermatologists regardless of  its efficacy 
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Table 4: Distribution of treatment response and side effects according to the treatment types (n=44)
Variable Cryotherapy (n=22) No. (%) Trichloroacetic acid (n=22) No. (%) P-value
Response
0.02**Good 16 (72.8) 9 (40.9)
Moderate 5 (22.7) 5 (22.7)
Poor 1 (4.5) 8 (36.4)
Redness
Yes 22 (100.0) 22 (100.0) -
No 0 (0) 0 (0)
Dyspigmentation 0.1*
No 6 (27.3) 6 (27.3)
Hyperpigmentation 10 (45.5) 16 (68.2)
Hypopigmentation 6 (27.3) 1 (4.5)
*Not significant, **Significant; Good response=complete disappearance of the lesion; Moderate response=partial disappearance of the lesion; Poor response=lesion is still present 
regardless of size
or safety (Uhlenhake, 2013). The main study limitations were 
a short duration of  the study which needs longer time for 
evaluation and assessment, in addition to the loss of  some 
patients during follow-up period which was five patients in 
cryotherapy group and three patients in TCA group.
5. CONCLUSIONS
Cryotherapy is highly effective in treating the AK than TCA 
25%. Further researches on effectiveness and safety of  
cryotherapy in treatment for AK are needed.
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